United Therapeutics Corporation (UTHR)
NASDAQ·Healthcare·Biotechnology
$525.86
+0.43%
Mkt Cap $22.43B
Analyst Ratings
Buy
12
Hold
6
Sell
0
Price Target (38 analysts)
$636.83
Range $516.00 – $735.00
Implied Upside
+21.1%
Consensus $636.83 vs current $525.86